KR101706754B1 - residual product of fish protein having reduced antigencity and improved antioxidant activity - Google Patents
residual product of fish protein having reduced antigencity and improved antioxidant activity Download PDFInfo
- Publication number
- KR101706754B1 KR101706754B1 KR1020140134780A KR20140134780A KR101706754B1 KR 101706754 B1 KR101706754 B1 KR 101706754B1 KR 1020140134780 A KR1020140134780 A KR 1020140134780A KR 20140134780 A KR20140134780 A KR 20140134780A KR 101706754 B1 KR101706754 B1 KR 101706754B1
- Authority
- KR
- South Korea
- Prior art keywords
- fish
- hydrolyzate
- reaction
- reduced
- saccharified
- Prior art date
Links
- 108010028690 Fish Proteins Proteins 0.000 title claims abstract description 39
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 32
- 241000251468 Actinopterygii Species 0.000 claims abstract description 27
- 239000006227 byproduct Substances 0.000 claims abstract description 19
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 15
- 239000004365 Protease Substances 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 108091005804 Peptidases Proteins 0.000 claims abstract description 10
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 8
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 6
- 210000000936 intestine Anatomy 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 26
- 230000007062 hydrolysis Effects 0.000 claims description 18
- 238000006460 hydrolysis reaction Methods 0.000 claims description 18
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 9
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 9
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 9
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical group CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 8
- 239000003531 protein hydrolysate Substances 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 235000019419 proteases Nutrition 0.000 claims description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 6
- 238000011033 desalting Methods 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 108090000526 Papain Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 102000006386 Myelin Proteins Human genes 0.000 claims description 3
- 108010083674 Myelin Proteins Proteins 0.000 claims description 3
- 102000005158 Subtilisins Human genes 0.000 claims description 3
- 108010056079 Subtilisins Proteins 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- 229960002376 chymotrypsin Drugs 0.000 claims description 3
- 108010007119 flavourzyme Proteins 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 108010009355 microbial metalloproteinases Proteins 0.000 claims description 3
- 210000005012 myelin Anatomy 0.000 claims description 3
- 150000002972 pentoses Chemical class 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 235000019750 Crude protein Nutrition 0.000 claims description 2
- 150000002402 hexoses Chemical class 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 6
- 239000007857 degradation product Substances 0.000 abstract description 25
- 230000017854 proteolysis Effects 0.000 abstract description 25
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 230000001603 reducing effect Effects 0.000 abstract description 8
- 208000026935 allergic disease Diseases 0.000 abstract description 7
- 230000007815 allergy Effects 0.000 abstract description 7
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 102000035122 glycosylated proteins Human genes 0.000 abstract 1
- 108091005608 glycosylated proteins Proteins 0.000 abstract 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 20
- 229960001340 histamine Drugs 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 241000269908 Platichthys flesus Species 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- CETXOEGRUBXUAL-UHFFFAOYSA-N 3-(hydroxymethyl)furan-2-carbaldehyde Chemical compound OCC=1C=COC=1C=O CETXOEGRUBXUAL-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- OMRLTNCLYHKQCK-DHGKCCLASA-N 4-nitrophenyl N-acetyl-beta-D-glucosaminide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([N+]([O-])=O)C=C1 OMRLTNCLYHKQCK-DHGKCCLASA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003011 anion exchange membrane Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 1
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940054441 o-phthalaldehyde Drugs 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- -1 sodium carbohydrate Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/305—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances of undetermined constitution characterised by their preparation
- A24B15/306—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances of undetermined constitution characterised by their preparation one reactant being an amino acid or a protein, e.g. Maillard's reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 항원성이 저감되고 항산화활성이 우수한 당화 어류단백 분해물 및 이의 제조방법에 관한 것으로 내장이 제거된 어류 부산물 또는 어류 단백질을 단백질 분해효소로 가수분해하는 단계; 및 상기 가수분해된 가수분해물과 당류를 혼합하여 마이얄(Maillaird)반응 시키는 단계;를 포함함으로써, 우수한 항산화 활성 및 알러지 저감효과를 가질 수 있다. The present invention relates to a glycosylated protein degradation product having reduced antigenicity and excellent antioxidation activity and a method for producing the same, which comprises hydrolyzing a fish by-product or a fish protein from which the intestines have been removed into protease; And a step of reacting the hydrolyzed hydrolyzate with a saccharide to perform a Maillaird reaction, thereby having an excellent antioxidative activity and an allergy reducing effect.
Description
본 발명은 우수한 항산화 활성 및 알러지 저감효과를 갖는 어류단백 분해물 및 이의 제조방법에 관한 것이다.The present invention relates to a fish protein degradation product having an excellent antioxidative activity and an allergy reducing effect, and a process for producing the same.
우리나라의 어류중에서 넙치의 양식 산업은 해수어류 양식산업 전체 생산량의 절반을 차지하며 전 세계에서 가장 많은 생산량(연간 5만 톤, 약 5천억 원)을 차지하고 있는데 이는 세계 최고의 생산 기술을 갖추고 있기 때문이다.Of the fish in Korea, the flounder aquaculture industry accounts for half of the total production of the sea fish culture industry and accounts for the largest production volume in the world (50,000 tons per year, about 500 billion won per year) because it has the world's best production technology .
최근 생물자원의 고갈에 대한 인식이 증가함과 동시에 환경공해로 여겨지던 식품가공부산물이 여러 분야에서 가치를 인정받고 있다. Recently, the perception of depletion of biological resources has increased, and food processing by-products, which are considered as environmental pollution, have been recognized in many fields.
우리나라에서 수산물의 총 공급량은 약 3,200만 톤(통계청 : 2012년)이며, 이 중 약 85%가 가공원료로써 이용되고 총량의 70%에 달하는 내장, 머리, 피부, 뼈, 및 잔육 등의 부산물은 사료로 이용되거나 폐기되어지는 실정이다. 이와 같이 해마다 많은 양의 수산가공 부산물들이 발생하고 있지만 이들을 효율적으로 이용하기 위한 연구가 미흡하여 유용자원의 낭비뿐만 아니라 환경오염을 초래하고 있다. The total supply of aquatic products in Korea is about 32 million tons (Statistics Korea: 2012), of which about 85% is used as processing material and 70% of the total is by-products such as viscera, hair, skin, bones, It is used as feed or discarded. Although a large amount of fish processing by-products occur each year, there are insufficient researches to utilize them efficiently, resulting in waste of useful resources and environmental pollution.
상기 어류 가공부산물을 활용하기 위한 노력으로 이들 단백질 자원을 효소 분해를 통한 생활성(bioactive) 단백질과 펩타이드(peptide)로 회수하려는 노력들이 기울여 지고 있다. 또한, 어류 가공부산물을 효소적 생물학적 기법으로 분해하는 것은 생산 공정의 안정성, 부산물의 감소, 기능성 물질의 선택적 획득, 인체 안전성 면에서 장점이 있는 것으로 알려있다.In an effort to utilize the fish processing by-products, efforts are being made to recover these protein resources as bioactive proteins and peptides through enzymatic degradation. In addition, decomposition of fish processing by-products by enzymatic biological techniques is known to be advantageous in terms of stability of the production process, reduction of by-products, selective acquisition of functional materials, and human safety.
또한, 상기 어류 가공부산물은 단백질과 펩타이드, 아미노산과 핵산 등을 포함한 각종 정미 성분을 많이 가지고 있어 식품 소재나 베이스로서 좋은 원료가 될 수 있음에도 불구하고 어류의 특유의 냄새와 맛 성분으로 인해 비료나 사료로만 국한적으로 이용되고 있어, 이 자원을 부가가치가 높은 소재로 전환 시킨다면 기업의 수익증대에 기여할 뿐 아니라 소재개발 기술력을 축적함과 동시에 국가 경쟁력 제고 및 환경 친화 공정으로 인정을 받게 될 것이다.In addition, the fish processing by-products have many kinds of tastes including proteins, peptides, amino acids and nucleic acids, and thus they can be good raw materials for food materials and bases. However, due to the characteristic odor and taste of fish, If this resource is converted into high value added material, it will contribute not only to increase profit of company but also to accumulate technology of material development, and it will be recognized as national competitiveness enhancement and environment friendly process.
한편, 고압 처리 기술은 식품산업에서 주로 식품 중의 유해 미생물의 살균목적으로 사용된다. 그러나 최근 국내 및 일본을 중심으로 동식물 원료로부터 유용성분의 색상, 향미 및 영양성분 등을 유지하면서 수용화 및 추출증대 효과를 제공할 수 있는 비가열 기술로서의 장점이 부각되고 있다. 최근 상업적 규모의 고압 처리장치의 개발로 인하여 중소 식품소재 및 미용소재 제조업체를 중심으로 활용도가 점차적으로 증가하는 추세에 있다.On the other hand, high-pressure treatment technology is mainly used in the food industry for the purpose of sterilizing harmful microorganisms in foods. However, recently, the advantages of non-heating technology that can provide water-soluble and extracting effect while keeping the color, flavor and nutrients of the useful ingredient from the animal and plant raw materials centering on domestic and Japan have been highlighted. Recently, due to the development of high-pressure processing equipment of commercial scale, the utilization rate has been gradually increasing mainly in the manufacture of small-sized food material and beauty material.
또한, 마이얄 반응(MR)은 비효소적 갈색화 반응으로 아미노산, 펩타이드, 단백질의 아미노기와 환원당의 카보닐기와의 축합에 의하여 시작되는 일련의 반응이다. 이 반응은 소위 MRPs라 불리는 다수의 반응 물질들을 생산하는데 이들이 저장 또는 가공식품의 품질과 기호도에 중요한 역할을 한다.In addition, Maillal reaction (MR) is a series of reactions initiated by the condensation of the amino groups of amino acids, peptides, and proteins with the carbonyl group of the reducing sugar in a nonenzymatic browning reaction. This reaction produces a number of reactive substances called so-called MRPs, which play an important role in the quality and taste of stored or processed food.
본 발명의 목적은 내장이 제거된 어류 부산물을 효소로 가수분해한 후 마이얄 반응으로 당화시킴으로써 우수한 항산화 활성 및 알러지 저감효과를 갖는 당화 어류단백 분해물을 제공하는데 있다.An object of the present invention is to provide a hydrolyzate of a saccharified fish protein having an excellent antioxidative activity and an allergy reducing effect by hydrolyzing a fish by-product from which the intestines have been removed with an enzyme and saccharifying it by a Maial reaction.
또한, 본 발명의 다른 목적은 상기 당화 어류단백 분해물을 제조하는 방법을 제공하는데 있다.It is another object of the present invention to provide a method for producing the protein hydrolyzate of the saccharified fish.
상기한 목적을 달성하기 위한 본 발명의 항원성이 저감되고 항산화 활성이 우수한 당화 어류단백 분해물의 제조방법은 내장이 제거된 어류 부산물 또는 어류 단백질을 단백질 분해효소로 가수분해하는 단계; 및 상기 가수분해된 가수분해물과 당류를 혼합하여 마이얄(Maillaird) 반응시키는 단계;를 포함할 수 있다.In order to accomplish the above object, the present invention provides a method for producing a proteinaceous hydrolyzate of saccharified fish having reduced antigens and antioxidative activity, which comprises hydrolyzing a fish by-product or a fish protein with a protease by protease; And a step of reacting the hydrolyzed hydrolyzate with a saccharide to perform a Maillaird reaction.
상기 가수분해하는 단계 및 마이얄 반응시키는 단계 사이에 상기 가수분해물을 탈염시키는 단계를 더 포함할 수 있다. 또한, 상기 탈염시키는 단계 및 마이얄반응 시키는 단계 사이에 원하는 분자량을 갖도록 상기 탈염된 가수분해물을 획분하는 단계를 더 포함할 수 있다.And further desalting the hydrolyzate between the step of hydrolyzing and the step of performing myial reaction. Further, the step of separating the desalted hydrolyzate may further include separating the desalted hydrolyzate so as to have a desired molecular weight between the desalting step and the Myial reaction step.
상기 단백질 분해효소는 프로타멕스(Protamex), 플라보자임(Flavourzyme), 뉴트라제(Neutrase), 알카라제(Alcalase), 키모트립신(α-chymotrypsin), 트립신(Trypsin) 및 파파인(Papain)으로 이루어진 군에서 선택된 1종 이상일 수 있다.The proteolytic enzyme may be selected from the group consisting of Protamex, Flavourzyme, Neutrase, Alcalase,? -Chymotrypsin, Trypsin and Papain. And may be at least one selected from the group consisting of
상기 어류 부산물 또는 어류 단백질과, 단백질 분해효소의 중량비는 40 내지 100 : 1일 수 있다.The weight ratio of the fish by-product or fish protein to the proteolytic enzyme may be 40-100: 1.
상기 가수분해 시 온도는 40 내지 80 ℃, 가수분해 시 pH는 6.0 내지 7.5일 수 있다.The temperature for the hydrolysis may be 40 to 80 占 폚, and the pH for hydrolysis may be 6.0 to 7.5.
당류는 리보스, 자일로스 및 아라비로스로 이루어진 군에서 선택된 1종 이상의 5탄당 또는 글루코오스, 갈락토오스, 만노오스 및 프룩토오스로 이루어진 군에서 선택된 1종 이상의 6탄당일 수 있다.The saccharide may be at least one pentane selected from the group consisting of ribose, xylose and arabinose, or at least one 6-valent sugar selected from the group consisting of glucose, galactose, mannose and fructose.
상기 가수분해물과 당류는 1 : 1 내지 5의 중량비로 혼합될 수 있다.The hydrolyzate and the saccharide may be mixed in a weight ratio of 1: 1 to 5.
상기 마이얄 반응온도는 100 내지 150 ℃, 마이얄 반응압력은 0.2 내지 3 kg/㎠, 마이얄 반응 시 pH는 7 내지 9 및 마이얄 반응시간은 20 내지 60분일 수 있다.The Maillard reaction temperature may be from 100 to 150 ° C, the Maillard reaction pressure may be from 0.2 to 3 kg / cm 2, the Maillal reaction pH may be from 7 to 9, and the Maillet reaction time may be from 20 to 60 minutes.
상기 획분은 한외여과막을 이용할 수 있으며, 상기 획분된 가수분해물의 분자량은 5 KDa 이하일 수 있다.The fraction may be an ultrafiltration membrane, and the molecular weight of the fractionated hydrolyzate may be 5 KDa or less.
또한, 상기한 다른 목적을 달성하기 위한 본 발명의 당화 어류단백 분해물은 가수분해된 어류단백 분해물을 마이얄(Maillaird)반응시킨 것 일 수 있다.In order to accomplish the above-mentioned other objects, the saccharified fish protein degradation product of the present invention may be a Maillaird-reacted hydrolyzed fish protein degradation product.
상기 당화 어류단백 분해물은 0.5 내지 20 mg/㎖의 농도로 사용될 수 있다.The saccharified fish protein degradation product may be used at a concentration of 0.5 to 20 mg / ml.
상기 당화 어류단백 분해물의 가수분해도는 10 내지 13%, 갈변도는 550 내지 650, HMF(hydroxymethylfural) 함량은 30 내지 120 ugHMF/mg당화어류단백분해물, 및 분자량은 80 Da 내지 100 Da과 7 kDa 내지 47 kDa이 2 : 8의 중량비로 분포될 수 있다.The protein hydrolyzate of the saccharified fish protein is 10 to 13%, the degree of browning is 550 to 650, the HMF (hydroxymethylfural) content is 30 to 120 ug HMF / mg saccharified fish protein degradation product , and the molecular weight is 80 Da to 100 Da and 7 kDa To 47 kDa can be distributed in a weight ratio of 2: 8.
본 발명의 어류단백 분해물은 어류를 고압으로 가수분해한 후 마이얄 반응으로 당화시켜 제조함으로써 우수한 항산화 활성 및 알러지 저감효과를 갖는다.The fish protein degradation product of the present invention has excellent antioxidative activity and allergy reducing effect by producing fish by hydrolysis of fish at high pressure and saccharification by Meal reaction.
또한, 버려지는 부산물을 모두 이용하며 화학 첨가물이 들어가지 않으므로 친환경적인 식품첨가물 소재이다.In addition, it uses all of the by-products that are discarded and does not contain chemical additives, so it is an eco-friendly food additive material.
도 1은 본 발명의 일 실시례에 따라 제조된 어류단백 분해물에 대한 분자량을 증기화광산란검출기가 장착된 고속액체크로마토그래피로 측정한 그래프이다. 1 is a graph showing the molecular weight of a fish protein degraded product prepared according to an embodiment of the present invention by high performance liquid chromatography equipped with a vaporization light scattering detector.
본 발명은 우수한 항산화 활성 및 알러지 저감효과를 갖는 어류단백 분해물 및 이의 제조방법에 관한 것이다.
The present invention relates to a fish protein degradation product having an excellent antioxidative activity and an allergy reducing effect, and a process for producing the same.
이하, 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명의 어류단백 분해물의 제조방법은 내장이 제거된 어류 부산물 또는 어류 단백질을 단백질 분해효소로 가수분해하는 단계; 및 상기 가수분해된 가수분해물과 당류를 혼합하여 마이얄(Maillaird)반응 시키는 단계;를 포함한다. 또한, 상기 가수분해하는 단계 및 마이얄 반응시키는 단계 사이에 순차적으로 상기 가수분해물을 탈염시키는 단계 및 상기 탈염된 가수분해물을 획분하는 단계를 더 포함할 수 있다.The method for producing a fish protein degradation product of the present invention comprises the steps of hydrolyzing a fish by-product or a fish protein from which the intestines have been removed into a protease; And a step of reacting the hydrolyzed hydrolyzate with a saccharide to perform Maillaird reaction. Further, the method may further include desorbing the hydrolyzate sequentially between the hydrolysis step and the Myial reaction step, and further dividing the desalted hydrolyzate.
먼저, 내장이 제거된 어류 부산물 또는 어류 단백질을 및 단백질 분해효소를 80 내지 300 MPa, 바람직하게는 100 내지 150 MPa의 압력; 40 내지 80 ℃, 바람직하게는 50 내지 60 ℃의 온도; 6.0 내지 7.5, 바람직하게는 6.0 내지 7.0의 pH;하에서 1 내지 6시간 동안 가수분해한다.First, the fish by-product or fish protein from which the intestines have been removed and the protease are subjected to a pressure of 80 to 300 MPa, preferably 100 to 150 MPa; A temperature of 40 to 80 캜, preferably 50 to 60 캜; Hydrolysis is carried out for 1 to 6 hours under a pH of 6.0 to 7.5, preferably 6.0 to 7.0.
이때, 상기 어류 부산물(또는 어류 단백질)과 효소의 중량비는 40 내지 100 : 1, 바람직하게는 45 내지 60 : 1이다. 어류 부산물(또는 어류 단백질)과 효소의 중량비가 효소를 기준으로 상기 하한치 미만인 경우에는 하기 획분 시 원하는 분자량의 획분 수율이 현저히 낮아질 수 있으며, 상기 상한치 초과인 경우에는 가수분해 효율이 떨어질 수 있다. At this time, the weight ratio of the fish by-product (or fish protein) and the enzyme is 40 to 100: 1, preferably 45 to 60: 1. When the weight ratio of the fish by-product (or fish protein) and the enzyme is less than the lower limit based on the enzyme, the fraction yield of the desired molecular weight may be significantly lowered at the following fractionation, and the hydrolysis efficiency may be lowered above the upper limit.
또한, 가수분해 시 압력이 상기 하한치 미만인 경우에는 가수분해 효율이 떨어질 수 있으며, 상기 상한치 초과인 경우에는 하기 획분 시 원하는 분자량의 획분 수율이 현저히 낮아질 수 있다.If the pressure is lower than the lower limit, the hydrolysis efficiency may be lowered. If the pressure exceeds the upper limit, the yield of the desired molecular weight fraction may be significantly lowered.
또한, 가수분해 시 온도가 상기 하한치 미만인 경우에는 가수분해 효율이 떨어질 뿐만 아니라 하기 획분 시 원하는 분자량의 획분 수율이 현저히 낮아질 수 있으며, 상기 상한치 초과인 경우에는 하기 획분 시 원하는 분자량의 획분 수율이 현저히 낮아질 수 있다.In addition, when the temperature is lower than the lower limit, hydrolysis efficiency is lowered, and the yield of fraction of desired molecular weight at the subsequent fractionation can be significantly lowered. When the temperature is above the upper limit, the yield of fraction of desired molecular weight is significantly lowered .
또한, 가수분해 시 pH는 완충액으로 조절하는데, pH가 상기 범위를 벗어나는 경우에는 가수분해 효율이 떨어지고 하기 획분 시 원하는 분자량의 획분 수율이 현저히 낮아질 수 있다.When the pH is outside the above range, the hydrolysis efficiency is lowered and the yield of the desired molecular weight fraction may be significantly lowered at the subsequent fractionation.
상기 가수분해 시 어류 부산물 및 효소, 압력, 온도, pH 및 시간 중에서 하나라도 상기 범위를 벗어나는 경우에는 가수분해 효율 및 하기 획분 시 원하는 분자량의 획분 수율이 현저히 낮아질 수 있다.If any of the fish by-products and enzymes, pressure, temperature, pH, and time are out of the above range during the hydrolysis, the hydrolysis efficiency and the yield of the desired molecular weight fraction may be significantly lowered.
상기 어류로는 조단백 함량이 18 중량% 이상인 어류라면 특별히 한정되지 않지만, 바람직하게는 가자미(넙치), 도다리 및 광어로 이루어진 군에서 선택된 1종을 들 수 있다.The fishes are not particularly limited as long as they have a crude protein content of 18% by weight or more, and preferably one species selected from the group consisting of flounder (flounder), brassiere, and abalone.
또한, 상기 단백질 분해효소로는 프로타멕스(Protamex), 플라보자임(Flavourzyme), 뉴트라제(Neutrase), 알카라제(Alcalase), 키모트립신(α-chymotrypsin), 트립신(Trypsin) 및 파파인(Papain)으로 이루어진 군에서 선택된 1종 이상, 바람직하게는 프로타멕스, 플라보자임 또는 이들의 혼합효소, 더욱 바람직하게는 프로타멕스를 들 수 있다.Examples of the protease include Protamex, Flavourzyme, Neutrase, Alcalase,? -Chymotrypsin, trypsin and papain. Papain), preferably protamex, flavozymes, or a mixed enzyme thereof, more preferably, protamex.
다음으로, 생체 유효성을 높이기 위하여 상기 가수분해된 가수분해물을 탈염시킨다.Next, the hydrolyzed hydrolyzate is desalted to enhance bioavailability.
상기 가수분해물을 탈염시키는 방법은 특별히 한정되지 않지만, 바람직하게는 전기 탈염기(electrodialyzer)를 이용하여 이온 교환막과 전기의 힘에 의한 강제적 투석법으로 탈염을 진행한다. The method of desalting the hydrolyzate is not particularly limited, but desalting is preferably carried out by a forced dialysis method using an ion exchange membrane and an electric force using an electrodialyzer.
구체적으로, 상기 탈염법은 양이온 교환막과 음이온 교환막을 조합하여 상기 두 교환막 사이에 상기 가수분해물을 투입한 후 직류 전압을 인가하여 전기적으로 이온을 상기 가수분해물로부터 제거하는 방법이다.Specifically, the desalting method is a method in which a cation exchange membrane and an anion exchange membrane are combined, the hydrolyzate is put between the two exchange membranes, and then a DC voltage is applied to electrically remove ions from the hydrolyzate.
다음으로, 생체이용성 및 이후의 마이얄(Maillaird)반응의 효율성을 향상시키기 위하여 상기 탈염된 가수분해물을 획분하여 원하는 분자량, 예컨대 5 KDa 이하, 바람직하게는 0.1 내지 3 KDa의 분자량을 갖는 가수분해물을 획분한다.Next, in order to improve the bioavailability and subsequent efficiency of the Maillaird reaction, the desalted hydrolyzate is fractionated to obtain a hydrolyzate having a desired molecular weight, for example, a molecular weight of 5 KDa or less, preferably 0.1 to 3 KDa Respectively.
상기 획분된 가수분해물의 분자량이 5 KDa 초과인 경우에는 얻어지는 양(수율)이 낮으며 항산화 및 알러지 저감과 같은 생체이용성이 떨어지고 마이얄 반응이 원활하게 수행되지 못할 수 있다.When the molecular weight of the fractionated hydrolyzate is more than 5 KDa, the yield (yield) is low and the bioavailability such as antioxidation and allergy reduction is low and the Maillard reaction may not be performed smoothly.
상기 가수분해물을 획분하는 공정은 한외여과막을 장착한 한외여과 시스템을 이용하여 분획한 후 농축하고 동결건조한 것이다.The step of fractionating the hydrolyzate is carried out by fractionation using an ultrafiltration system equipped with an ultrafiltration membrane, followed by concentration and lyophilization.
다음으로, 상기 가수분해물(또는 획분된 가수분해물)과 당류를 혼합하여 마이얄 반응으로 당화시킨다.Next, the hydrolyzate (or the fractionated hydrolyzate) and the saccharide are mixed and saccharified by a Maial reaction.
상기 가수분해물과 당류를 1 : 1 내지 5의 중량비, 바람직하게는 1 : 2 내지 4의 중량비로 혼합하고 물을 첨가한 후 100 내지 150 ℃, 바람직하게는 110 내지 130 ℃ 하에서 0.2 내지 3 kg/㎠, 바람직하게는 0.6 내지 1.5 kg/㎠의 압력으로 20 내지 60분, 바람직하게는 30 내지 45분 동안 반응시켜 당화된 가수분해물, 예컨대 당화된 어류단백 분해물을 제조한다. 이때의 pH는 7 내지 9, 바람직하게는 8.2이다. The hydrolyzate and the saccharide are mixed at a weight ratio of 1: 1 to 5, preferably 1: 2 to 4, and water is added. The mixture is then heated at 100 to 150 ° C, preferably 110 to 130 ° C, Cm 2, preferably 0.6 to 1.5 kg / cm 2 for 20 to 60 minutes, preferably 30 to 45 minutes, to produce a glycosylated hydrolyzate such as glycated fish protein degradation product. The pH at this time is 7 to 9, preferably 8.2.
분획된 가수분해물과 당류의 중량비가 가수분해물을 기준으로 상기 하한치 미만인 경우에는 항산화능과 항알러지 효과가 낮으며, 상기 상한치 초과인 경우에는 마이얄 반응 시 부반응이 다량 발생할 수 있다.When the weight ratio of the hydrolyzate and the saccharide is lower than the lower limit of the hydrolyzate, the antioxidant activity and the antiallergic effect are low. If the weight ratio of the hydrolyzate and the saccharide is higher than the upper limit, a large amount of side reactions may occur at the time of the myelin reaction.
또한, 온도 및 압력이 상기 하한치 미만인 경우에는 항산화능과 항알러지 효과가 낮으며, 상기 상한치 초과인 경우에는 독성물질이 생길 수 있다.When the temperature and the pressure are lower than the lower limit, the antioxidant ability and the anti-allergic effect are low. If the temperature and the pressure are higher than the upper limit, toxic substances may be generated.
또한, pH가 상기 범위를 벗어나는 경우에는 항산화능과 항알러지 효과가 발생하지 않을 수 있다.When the pH is out of the above range, antioxidant activity and anti-allergic effect may not occur.
상기 당류로는 5탄당 또는 6탄당을 들 수 있으며, 구체적으로 리보스, 자일로스 및 아라비로스로 이루어진 군에서 선택된 1종 이상인 5탄당; 글루코오스, 갈락토오스, 만노오스 및 프룩토오스로 이루어진 군에서 선택된 1종 이상인 6탄당을 들 수 있으며, 바람직하게는 5탄당인 리보스이다. 상기 당류로 리보스를 사용하는 경우에는 6탄당의 당류를 사용하는 경우에 비하여 마이얄 반응이 잘 일어나고 갈변도 및 항산화능이 더 우수하다.Examples of the saccharides include pentose and hexose, and specifically include pentose, which is at least one selected from the group consisting of ribose, xylose and arabinose; Glucose, glucose, galactose, mannose, and fructose, and is preferably ribose, which is pentane. In the case of using the ribose as the saccharide, the myelin reaction occurs well and the browning and antioxidant ability are better than the case of using the saccharide per 6 carbon atoms.
상기와 같은 방법으로 제조된 당화 어류단백 분해물은 0.5 내지 20 mg/㎖, 바람직하게는 1 내지 5 mg/㎖, 더욱 바람직하게는 1 mg/㎖의 농도로 사용한다.The saccharified fish protein solution prepared by the above method is used at a concentration of 0.5 to 20 mg / ml, preferably 1 to 5 mg / ml, more preferably 1 mg / ml.
당화 어류단백 분해물의 사용량이 상기 하한치 미만인 경우에는 기대하는 효과를 얻을 수 없으며, 상기 상한치 초과인 경우에는 독성이 발생할 수 있다.When the amount of the saccharified fish protein degradation product is less than the lower limit, the expected effect can not be obtained. If the upper limit is exceeded, toxicity may occur.
또한, 본 발명의 어류단백 분해물은 가수분해도가 10 내지 13%, 갈변도가 550 내지 650, HMF(hydroxymethylfural) 함량이 30 내지 120 ugHMF/mg당화어류단백분해물, 및 분자량이 80 Da 내지 100 Da과 7 kDa 내지 47 kDa이 2 : 8의 중량비로 분포될 수 있다(도 1). 상기 도 1의 당화 어류단백 분해물의 분자량은 증기화광산란검출기(evaporating light scattering detector)가 장착된 고속액체크로마토그래피(1200 series, Agilent, 미국)를 사용하여 젤여과크로마토그래피법으로 분석하였다. 분석조건은 시료 50 ul를 주입한 후 Agilent PL aquagel-OH 30 (8 um, 300 x 7.5 mm) 컬럼에 이동상인 0.02% sodium azide를 0.5 ml/min의 유속으로 용출하여 분자량별로 검출하였고, Easivial PEG/PEO(Agilent, 미국)을 표준물질로 비교분석하여 분자량 분포를 확인하였다.In addition, the fish protein degradation product of the present invention has a hydrolyzed degree of 10 to 13%, a browning degree of 550 to 650, a HMF (hydroxymethylfural) content of 30 to 120 ug HMF / mg saccharified fish protein degradation product and a molecular weight of 80 Da to 100 Da And 7 kDa to 47 kDa in a weight ratio of 2: 8 (Fig. 1). The molecular weight of the saccharified protein hydrolyzate of FIG. 1 was analyzed by gel filtration chromatography using high performance liquid chromatography (1200 series, Agilent, USA) equipped with an evaporating light scattering detector. The analytical conditions were as follows: After injecting 50 μl of sample, 0.02% sodium azide was eluted at a flow rate of 0.5 ml / min on a Agilent PL aquagel-OH 30 column (8 μm, 300 × 7.5 mm) / PEO (Agilent, USA) were compared with standard materials to confirm the molecular weight distribution.
또한, 본 발명의 어류단백 분해물은 히스타민 방출양(%)이 190 내지 300%, β-히소사미니다이즈 방출양(%)이 90 내지 130%, DPPH 라디칼 소거능(%)이 0.4 내지 1.2 mg/㎖, 및 FRAP(Ferric reducing ability of plasma) 활성이 2.00 내지 3.00 mM FeSO4 eq./mg extract이다.
In addition, the fish protein degradation product of the present invention has 190-300% histamine release (%), 90-130% beta-histamine release (%), DPPH radical scavenging activity (0.4-1.2 mg / and a FRAP (Ferric reducing ability of plasma) activity of 2.00 to 3.00 mM FeSO 4 eq./mg extract.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the present invention. Such variations and modifications are intended to be within the scope of the appended claims.
실시예 1.Example 1.
내장을 제거한 넙치를 습식 분쇄기로 분쇄한 넙치가루 100 중량부와 프로타멕스 2 중량부를 혼합한 후 100 MPa의 압력, 57 ℃의 온도 및 pH 6.8 하에서 6시간 동안 가수분해한 다음 이를 농축하고 동결건조하고 상기 동결건조된 가수분해물 100 중량부와 리보스 100 중량부를 혼합한 후 물을 첨가하고 121 ℃의 온도, 1.0 kg/㎠의 압력 및 pH 8.2하에서 38분 동안 마이얄 반응시켜 당화 어류단백 분해물을 제조하였다.
100 parts by weight of flounder flour milled with a wet crusher and 2 parts by weight of protamex were mixed and then hydrolyzed at a pressure of 100 MPa and a temperature of 57 DEG C and pH 6.8 for 6 hours and then concentrated and lyophilized 100 parts by weight of the lyophilized hydrolyzate and 100 parts by weight of ribose were mixed and water was added thereto. The mixture was subjected to a Maillard reaction at 121 ° C, 1.0 kg / cm 2 pressure and pH 8.2 for 38 minutes to prepare a saccharified fish protein degradation product Respectively.
실시예 2.Example 2.
내장을 제거한 넙치를 습식 분쇄기로 분쇄한 넙치가루 100 중량부와 프로타멕스 2 중량부를 혼합한 후 100 MPa의 압력, 57 ℃의 온도 및 pH 6.8 하에서 6시간 동안 가수분해한 다음 전기 탈염기(Micro-acilyzer S3, 창조테크노, 한국)를 이용하여 탈염된 가수분해물을 얻었다. 상기 탈염된 가수분해물을 한외여과막장치(QuixStandtm benchtop system, GE healthcare, 미국)를 이용하여 분획함으로써 3 KDa이하의 분자량을 갖는 분획된 가수분해물을 얻고 이를 농축하고 동결건조하였다. 상기 분획된 가수분해물 100 중량부와 리보스 100 중량부를 혼합한 후 물을 첨가하고 121 ℃의 온도, 1.0 kg/㎠의 압력 및 pH 8.2하에서 38분 동안 마이얄 반응시켜 당화 어류단백 분해물을 제조하였다.
100 parts by weight of flounder flour milled with a wet grinder and 2 parts by weight of protamex were mixed and then hydrolyzed at a pressure of 100 MPa, a temperature of 57 DEG C and a pH of 6.8 for 6 hours, -acilyzer S3, Creation Techno, Korea) to obtain a desalted hydrolyzate. The desalted hydrolyzate was fractionated using an ultrafiltration system (QuixStandtm benchtop system, GE healthcare, USA) to obtain a fractionated hydrolyzate having a molecular weight of 3 KDa or less, which was concentrated and lyophilized. 100 parts by weight of the fractionated hydrolyzate and 100 parts by weight of ribose were mixed, and water was added thereto. The mixture was subjected to a Maillard reaction at 121 ° C, 1.0 kg / cm 2 pressure and pH 8.2 for 38 minutes to prepare saccharified fish protein degradation product.
실시예 3.Example 3.
상기 실시예 2와 동일하게 실시하되, 상기 분획된 가수분해물로 3.1 내지 5.0 KDa의 분자량을 갖는 분획된 가수분해물을 이용하여 당화 어류단백 분해물을 제조하였다.
The hydrolyzate of the saccharified fish protein was prepared using the fractionated hydrolyzate having a molecular weight of 3.1 to 5.0 KDa as the fractionated hydrolyzate.
실시예Example 4. 4.
상기 실시예 2와 동일하게 실시하되, 상기 리보스 대신 글루코스를 사용하여 당화 어류단백 분해물을 제조하였다.
The same procedure as in Example 2 was carried out except that the saccharified fish protein degradation product was prepared using glucose instead of the ribose.
실시예 5.Example 5.
상기 실시예 2와 동일하게 실시하되, 넙치가루 100 중량부에 대하여 프로타멕스 5 중량부를 사용하여 당화 어류단백 분해물을 제조하였다.
The same procedure as in Example 2 was conducted except that 5 parts by weight of protamex was used for 100 parts by weight of flounder flour to prepare saccharified fish protein degradation products.
실시예 6.Example 6.
상기 실시예 2와 동일하게 실시하되, 분획된 가수분해물로 10 KDa 이상의 분자량을 갖는 분획된 가수분해물을 이용하여 당화 어류단백 분해물을 제조하였다.
The hydrolyzate of the saccharified fish protein was prepared using the fractionated hydrolyzate having a molecular weight of 10 KDa or more as the fractionated hydrolyzate.
실시예 7.Example 7.
상기 실시예 2와 동일하게 실시하되, 분획된 가수분해물 100 중량부에 대하여 리보스 1000 중량부를 사용하여 당화 어류단백 분해물을 제조하였다. 이때의 pH는 4.2에서 4.9이다.
The protein hydrolysates of saccharified fish were prepared using 1000 parts by weight of ribose per 100 parts by weight of the hydrolyzate obtained in Example 2. The pH at this time is 4.2 to 4.9.
실시예Example 8. 8.
상기 실시예 2와 동일하게 실시하되, 마이얄 반응시 온도를 80 ℃로 하여 당화 어류단백 분해물을 제조하였다.
The protein hydrolyzate of Saccharomyces cerevisiae was prepared in the same manner as in Example 2 except that the temperature at the time of the Maial reaction was 80 ° C.
실시예Example 9. 9.
상기 실시예 2와 동일하게 실시하되, 마이얄 반응시 압력을 6 kg/㎠으로 하여 당화 어류단백 분해물을 제조하였다.
The same procedure as in Example 2 was carried out except that the saccharified fish protein degradation product was prepared at a pressure of 6 kg / cm 2 during the Maial reaction.
비교예Comparative Example 1. One.
상기 실시예 2와 동일하게 실시하되, 마이얄 반응을 수행하지 않고 당화 어류단백 분해물을 제조하였다.
The same procedure as in Example 2 was carried out except that the saccharified fish protein degradation product was prepared without carrying out the Myal reaction.
시험예Test Example 1. One. 알러젠Allen 활성 측정 Active measurement
실시예 및 비교예의 알러젠 활성을 측정하기 위하여 히스타민(histamine)과 β-히소사미니다이즈(β-hexosaminidase) 방출 실험을 진행하였다. 상기 히스타민과 β-히소사미니다이즈는 알러지 반응이 진행됨에 따라 세포 외부로 분비되는 물질로 RBL-2H3 cell을 이용하여 측정하였다.In order to measure the allergen activity of Examples and Comparative Examples, histamine and β-hexosaminidase release experiments were conducted. The histamine and? -Hisosaminidase were secreted to the outside of the cell as the allergic reaction progressed, and the cells were measured using RBL-2H3 cells.
1-1. 히스타민 방출: 히스타민 방출을 측정하기 위하여 RBL-2H3을 96-well plate에 5X104 cells/well로 분주한 후, 24시간 동안 배양하였다. 배지를 모두 제거한 후 PBS로 2번 세척하고 시료를 1 mg/mL의 농도로 방출 용액(116.9 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.6 mM Glucose, 25 mM HEPES, 2 mM CaCl2, 1 mg/mL BSA)에 희석하여 세포주에 처리한 후, 2시간 동안 배양하였다. 세포 배양 상등액 100 uL를 취한 후, 0.5N NaOH와 2.5 mg/mL의 o-Phthalaldehyde를 2:1의 비율로 섞은 용액 60 uL를 넣어 37 ℃에서 30분간 반응시키고 3 N HCl을 10 uL 넣어 반응을 종결시켰다. 형광도는 excitation 355 nm/emission 460 nm에서 측정하였으며, 다음 [수학식 1]을 이용하여 히스타민의 방출 정도를 계산하였다.1-1. Histamine release: To measure histamine release, RBL-2H3 was dispensed into a 96-well plate at 5 × 10 4 cells / well and cultured for 24 hours. After the medium was removed, the cells were washed twice with PBS, and the sample was diluted with the release solution (116.9 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.6 mM Glucose, 25 mM HEPES, 2 mM CaCl2, 1 mg / mL BSA), treated with the cell line, and cultured for 2 hours. Add 100 μL of the cell culture supernatant, add 60 μL of 0.5N NaOH and 2.5 mg / mL o-phthalaldehyde in a ratio of 2: 1, incubate at 37 ° C for 30 minutes, add 10 μL of 3 N HCl, Terminated. Fluorescence was measured at excitation 355 nm / emission 460 nm and the degree of release of histamine was calculated using the following equation (1).
1-2. β-히소사미니다이즈 방출: β-히소사미니다이즈 방출을 측정하기 위하여 RBL-2H3을 96-well plate에 5x104 cells/well로 분주한 후, 24시간 동안 배양하였다. 배지를 모두 제거한 후 PBS로 2번 세척하였다. 시료를 1 mg/mL의 농도로 방출 용액(116.9 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.6 mM Glucose, 25 mM HEPES, 2 mM CaCl2, 1 mg/mL BSA)에 희석하여 세포주에 처리한 후, 2시간 동안 배양하였다. 세포 배양 상등액 30 uL를 취하여 기질 용액(5 mM 4-Nitrophenyl-N-acetyl-β-D-glucosaminide in 0.05 M citrate buffer, pH 4.5) 70 uL와 37 ℃에서 1시간 동안 반응시켰다. 배양 후 0.1 M sodium carbohydrate buffer(pH 10)를 100 uL 첨가하여 반응을 종결시키고 multiplate reader를 이용하여 405 nm에서 흡광도를 측정하였다. 그 후 다음 [수학식 2]를 이용하여 β-히소사미니다이즈 방출 정도를 계산하였다.1-2. Release of β-hysosomal DNA: To measure β-histamine release, RBL-2H3 was dispensed into a 96-well plate at 5 × 10 4 cells / well and cultured for 24 hours. After the medium was removed, the cells were washed twice with PBS. The sample was diluted in a release solution (116.9 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.6 mM Glucose, 25 mM HEPES, 2 mM CaCl2, 1 mg / mL BSA) at a concentration of 1 mg / , And cultured for 2 hours. The cell culture supernatant (30 μL) was reacted with 70 μL of a substrate solution (5 mM 4-Nitrophenyl-N-acetyl-β-D-glucosaminide in 0.05 M citrate buffer, pH 4.5) at 37 ° C. for 1 hour. After incubation, 100 μL of 0.1 M sodium carbohydrate buffer (pH 10) was added to terminate the reaction and absorbance was measured at 405 nm using a multiplate reader. Then, the degree of? -Hisosamidine emission was calculated using the following formula (2).
위 표 1에 나타낸 바와 같이, 본 발명의 실시예 1 내지 9에 따라 제조된 어류단백 분해물은 비교예 1에 비하여 히스타민 및 히소사미니다이즈의 방출량이 1.5 내지 3배 정도 낮은 것으로 확인되었다. 특히, 실시예 1 내지 4는 실시예 5 내지 9에 비해서도 히스타민 및 히소사미니다이즈의 방출량이 낮은 것으로 확인되었다.As shown in Table 1, it was confirmed that the amounts of histamine and hysosaminidase released from the fish protein degradation products prepared according to Examples 1 to 9 of the present invention were 1.5 to 3 times lower than those of Comparative Example 1. In particular, Examples 1 to 4 were found to have lower levels of histamine and hysosaminidase release than Examples 5 to 9.
상기 히스타민 및 히소사미니다이즈의 방출량이 높다는 것은 알러지 반응을 유발시킬 수 있다는 것이므로 실시예 1 내지 9는 비교예에 비하여 알러지 억제 효과가 우수한 것을 확인하였다.
Since the high release of histamine and hysosaminidase can induce an allergic reaction, it is confirmed that Examples 1 to 9 are superior to all Comparative Examples in allergy suppressing effect.
시험예Test Example 2. 항산화 활성 측정 2. Antioxidant activity measurement
2-1. DPPH 라디칼 소거활성: 0.15 mM DPPH 용액(in 94.5 % ethanol) 45 uL에 EtOH 45 uL에 농도별로 증류수로 희석(1~5000배)한 각각의 GFPH 10 uL를 넣고 10초간 vortexing 한 후 암소에서 15분간 반응시킨 후에 515 nm에서 흡광도를 측정하였다. 측정값은 다음 [수학식 3]에 대입하여 계산하였고 IC50값은 각 시료의 DPPH radical 소거율이 50 %일 때의 희석배수(DF)로 산출하여 각 시료의 소거활성을 비교하였다.2-1. DPPH radical scavenging activity: To 45 μL of 0.15 mM DPPH solution (in 94.5% ethanol) was added 10 μL of each GFPH diluted with distilled water to 45 μL of EtOH, vortexed for 10 seconds, After the reaction, the absorbance was measured at 515 nm. The measured values were calculated by substituting into the following equation (3). IC 50 values were calculated by dilution factor (DF) when the DPPH radical scavenging rate of each sample was 50%, and the scavenging activity of each sample was compared.
2-2. FRAP(Ferric reducing ability of plasma) 활성: 300 mM acetate buffer (pH 3.6), 40 mM HCl에 용해한 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) 및 20 mM FeCl36H2O를 각각 10:1:1(v/v/v)의 비율로 혼합하여 37 ℃에서 10분 동안 가온한 후 FRAP 시약으로 사용하였다. 농도 5 mg/mL의 시료 10 uL를 FRAP 시약 90 uL와 혼합하여 37 ℃에서 5분간 반응시킨 후 593 nm에서 흡광도를 측정하였으며 FeSO4·7H2O를 표준물질로 하여 얻은 표준 검량선으로부터 계산하여 mM FeSO4 eq./mg extract로 표시하였다.2-2. Ferric reducing ability of plasma (FRAP) activity: 300 mM acetate buffer (pH 3.6), 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) dissolved in 40 mM HCl and 20 mM FeCl 3 6H 2 O 10: 1: 1 (v / v / v), and the mixture was heated at 37 ° C for 10 minutes and used as a FRAP reagent. 10 μL of a 5 mg / mL sample was mixed with 90 μL of FRAP reagent, reacted at 37 ° C. for 5 minutes, and the absorbance was measured at 593 nm. The calculated absorbance was calculated from a standard curve obtained using FeSO 4 · 7H 2 O as a standard FeSO 4 eq. / Mg extract.
위 표 2에 나타낸 바와 같이, 본 발명의 실시예 1 내지 9에 따라 제조된 어류단백 분해물은 비교예 1에 비하여 DPPH 소거능 및 FRAP 활성이 우수한 것을 확인하였다. 특히, 실시예 1 내지 4는 실시예 5 내지 9에 비해서도 DPPH 소거능 및 FRAP 활성이 우수한 것으로 확인되었다.As shown in Table 2 above, it was confirmed that the fish protein degradation products prepared according to Examples 1 to 9 of the present invention had better DPPH scavenging activity and FRAP activity than Comparative Example 1. In particular, Examples 1 to 4 were found to be more excellent in DPPH scavenging activity and FRAP activity than Examples 5 to 9.
상기 DPPH 소거능 및 FRAP 활성이 우수하다는 것은 항산화 활성이 우수하다는 것이므로 실시예 1 내지 9는 비교예에 비하여 우수한 항산화 활성을 보이는 것으로 확인되었다.
Since the excellent DPPH scavenging ability and FRAP activity are excellent in antioxidant activity, it was confirmed that Examples 1 to 9 exhibit superior antioxidative activities as compared with Comparative Examples.
시험예Test Example 3. 가수분해도, 갈변도 및 3. Hydrolysis, browning and HMFHMF 측정 Measure
3-1. 가수분해도: Standard로 Glycine(0.3125 mM~2.5 mM)을 사용하였으며, 100배 희석한 시료와 Standard를 96 well에 20 uL씩 분주한 뒤 Sodium bicarbonate buffer(pH 8.5) 50 uL를 각각 분주하고, 0.1 % TNBS를 50 uL 첨가하였다. 50 ℃의 Shaking Incubator에서 60분 동안 반응시킨 후, 10 % SDS를 넣어 단백질을 안정화 시키고 25 uL의 HCl로 반응을 종료시킨 후 Spectrometer(OD, 340 nm)에서 측정하여 아미노산 mM 값으로 변환하였다. 가수분해도는 넙치 부산물의 단백질 함량과 아미노산 분석을 통한 평균 분자량을 고려한 후 TNBS (Trinitrobenzenesulfonic Acid) assay를 이용하여 아미노산 mol 수를 분석하여 나타내었다.3-1. Glycine (0.3125 mM ~ 2.5 mM) was used as a standard. Dilute 100-fold diluted samples and standard in a volume of 20 μL into 96 wells, and add 50 μL of sodium bicarbonate buffer (pH 8.5) 50 uL TNBS was added. After incubation for 60 min in a shaking incubator at 50 ° C, the protein was stabilized by adding 10% SDS and the reaction was terminated with 25 μL of HCl. The reaction mixture was then measured by Spectrometer (OD, 340 nm) The degree of hydrolysis was determined by analyzing the molar number of amino acids using the TNBS (Trinitrobenzenesulfonic Acid) assay after considering the protein content of the flounder byproduct and the average molecular weight through amino acid analysis.
3-2. 갈변도: 실시예 및 비교예의 제조된 당화 어류단백 분해물 용액을 흡광도로 측정할 수 있는 0.2 내지 0.8 범위 내에 들도록 증류수로 희석(1 내지 500배)하여 spectrophotometer(DU650 spectrophotometer, Beckman, USA)를 사용하여 갈색색소의 측정범위인 420 nm에서 흡광도를 측정하여 갈변도를 측정하였다.3-2. Browning degree: The prepared saccharified fish protein degradation product solutions were diluted (1 to 500 times) with distilled water so as to be within the range of 0.2 to 0.8 which can be measured by absorbance, and then subjected to spectrophotometer (DU650 spectrophotometer, Beckman, USA) The degree of browning was measured by measuring the absorbance at 420 nm, which is the measurement range of the brown pigment.
3-3. HMF 함량: 실시예 및 비교예의 제조된 당화 어류단백 분해물의 당화 생성물(HMF)은 HPLC 분석 방법을 이용하여 측정하였다.3-3. HMF content: The glycated product (HMF) of the protein hydrolysates of the saccharified fish prepared in Examples and Comparative Examples was measured using HPLC analysis method.
위 표 3에 나타낸 바와 같이, 본 발명의 실시예 1 내지 9에 따라 제조된 당화 어류단백 분해물은 비교예 1에 비하여 가수분해도, 갈변도 및 HMF 함량 모두 우수한 것으로 확인되었다. 특히, 실시예 1 내지 4는 실시예 5 내지 9에 비해서도 가수분해도, 갈변도 및 HMF 함량이 우수한 것으로 확인되었다.
As shown in Table 3 above, it was confirmed that the saccharified fish protein degradation products prepared according to Examples 1 to 9 of the present invention were superior in both the hydrolysis degree, the browning degree and the HMF content, as compared with Comparative Example 1. In particular, it was confirmed that Examples 1 to 4 are superior to Examples 5 to 9 in the degree of hydrolysis, browning and HMF content.
상기 실시예 1 내지 4는 HepG2 세포주, RBL-2H3 세포주, NRK-52E 세포주를 이용하여 세포 생존능을 측정한 결과, 세포독성은 나타나지 않았으며, 1 mg/㎖ 수준에서는 세포독성 보다는 세포 성장을 더욱 촉진시키는 것을 확인하였다.
In the above Examples 1 to 4, cell viability was measured using HepG2 cell line, RBL-2H3 cell line, and NRK-52E cell line. As a result, no cytotoxicity was observed, and at 1 mg / .
Claims (22)
상기 가수분해물을 탈염시키는 단계;
상기 탈염된 가수분해물을 분획하여 분자량이 0.1 내지 3 kDa인 분획된 가수분해물을 수득하는 단계; 및
상기 분획된 가수분해물과 당류를 1 : 1 내지 5의 중량비로 혼합하여 마이얄(Maillaird) 반응시키는 단계;를 포함하는 것을 특징으로 하는 항원성이 저감되고 항산화 활성이 우수한 당화 어류단백 분해물의 제조방법.Mixing and hydrolyzing a fish by-product or a fish protein from which the intestines of the fish having a crude protein content of 18% or more are removed and a protease in a weight ratio of 40 to 100: 1;
Desalting the hydrolyzate;
Fractionating the desalted hydrolyzate to obtain a fractionated hydrolyzate having a molecular weight of 0.1 to 3 kDa; And
Mixing the fractionated hydrolyzate with a saccharide at a weight ratio of 1: 1 to 5 and then subjecting the mixture to a Maillaird reaction. The method for producing the protein hydrolyzate of a saccharified fish having excellent antioxidative activity with reduced antigenicity .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140134780A KR101706754B1 (en) | 2014-10-07 | 2014-10-07 | residual product of fish protein having reduced antigencity and improved antioxidant activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140134780A KR101706754B1 (en) | 2014-10-07 | 2014-10-07 | residual product of fish protein having reduced antigencity and improved antioxidant activity |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160054053A KR20160054053A (en) | 2016-05-16 |
KR101706754B1 true KR101706754B1 (en) | 2017-02-15 |
Family
ID=56108865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140134780A KR101706754B1 (en) | 2014-10-07 | 2014-10-07 | residual product of fish protein having reduced antigencity and improved antioxidant activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101706754B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107822196B (en) * | 2017-10-19 | 2019-11-08 | 湖北中烟工业有限责任公司 | The application of the tobacco aromaticss of the method preparation of tobacco aromaticss is prepared using xylose hydrolysis |
CN108651690B (en) * | 2018-04-25 | 2021-11-19 | 河南科技大学 | Process method for preparing functional egg white powder through synergistic modification of enzymolysis and glycosylation |
CN113061170B (en) * | 2019-12-16 | 2023-04-07 | 青海师范大学 | Alfalfa antioxidant glycoprotein and preparation method and application thereof |
CN112931923B (en) * | 2021-02-02 | 2022-12-02 | 云南中烟工业有限责任公司 | Preparation method of specific molecular weight peptide Maillard intermediate and application of intermediate in tobacco flavor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100998656B1 (en) | 2007-11-20 | 2010-12-07 | 대상 주식회사 | Method For Manufacturing Salmon Frame Extract |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4484058B2 (en) * | 2002-10-11 | 2010-06-16 | 味の素株式会社 | Fatigue recovery food composition |
KR100729255B1 (en) | 2005-04-25 | 2007-06-18 | 인제대학교 산학협력단 | A manufacturing process of marine products'flavor |
KR20110011387A (en) | 2009-07-28 | 2011-02-08 | 청강문화산업대학 산학협력단 | Natural antifugal composition comprising brown-colored reaction product prepared by maillaird reaction of an enzymatic discomposition of protamine with glucose and method for preparation thereof |
-
2014
- 2014-10-07 KR KR1020140134780A patent/KR101706754B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100998656B1 (en) | 2007-11-20 | 2010-12-07 | 대상 주식회사 | Method For Manufacturing Salmon Frame Extract |
Non-Patent Citations (1)
Title |
---|
한국수산학회지 Vol.19 No.2 pp.127-135(1986)* |
Also Published As
Publication number | Publication date |
---|---|
KR20160054053A (en) | 2016-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wen et al. | A mini‐review on brewer's spent grain protein: isolation, physicochemical properties, application of protein, and functional properties of hydrolysates | |
Echave et al. | Seaweed protein hydrolysates and bioactive peptides: Extraction, purification, and applications | |
Ding et al. | Optimization of pea protein hydrolysate preparation and purification of antioxidant peptides based on an in silico analytical approach | |
EP2774993B1 (en) | Effective use of yeast and yeast extract residue | |
Cui et al. | Purification and partial characterization of a novel anti-tumor glycoprotein from cultured mycelia of Grifola frondosa | |
CN105392797B (en) | Dipeptidyl peptidase-IV (DPPIV) inhibitory peptide compounds, compositions comprising the same, and methods of making the same | |
KR101706754B1 (en) | residual product of fish protein having reduced antigencity and improved antioxidant activity | |
Xu et al. | Antioxidant activities of sorghum kafirin alcalase hydrolysates and membrane/gel filtrated fractions | |
Yu et al. | Antioxidant and ACE inhibitory activity of enzymatic hydrolysates from Ruditapes philippinarum | |
KR20100031634A (en) | Yeast autolysates | |
Liao et al. | Preparation of antioxidant protein hydrolysates from Pleurotus geesteranus and their protective effects on H2O2 oxidative damaged PC12 cells | |
Li et al. | Identification of angiotensin I-converting enzyme inhibitory peptides derived from enzymatic hydrolysates of razor clam Sinonovacula constricta | |
Zhu et al. | Amino acid, structure and antioxidant properties of Haematococcus pluvialis protein hydrolysates produced by different proteases | |
Mazloomi et al. | Impact of simulated gastrointestinal digestion on the biological activity of an alcalase hydrolysate of orange seed (Siavaraze, Citrus sinensis) by-products | |
Pintathong et al. | The feasibility of utilizing cultured Cordyceps militaris residues in cosmetics: Biological activity assessment of their crude extracts | |
Sangiorgio et al. | Preparation, characterization and in vitro stability of a novel ACE-inhibitory peptide from soybean protein | |
Huang et al. | Production of yeast hydrolysates by Bacillus subtilis derived enzymes and antihypertensive activity in spontaneously hypertensive rats | |
Xue et al. | Isolation, purification, and structure identification of antioxidant peptides from embryonated eggs | |
Zhang et al. | Changes of antioxidative activities and peptidomic patterns of Auxenochlorella pyrenoidosa protein hydrolysates: Effects of enzymatic hydrolysis and decoloration processes | |
Dini et al. | Food Peptides for the Nutricosmetic Industry | |
Shen et al. | Biochemical properties and potential applications of recombinant leucine aminopeptidase from Bacillus kaustophilus CCRC 11223 | |
Liao et al. | Preparation and identification of an antioxidant peptide from wheat embryo albumin and characterization of its Maillard reaction products | |
Wei et al. | Identification and molecular docking of novel antioxidant peptides from Candida utilis | |
Kachrimanidou et al. | Valorization of Grape Pomace for Trametes versicolor Mycelial Mass and Polysaccharides Production | |
Feng et al. | Preparation and purification of angiotensin‐converting enzyme inhibitory peptides from hydrolysate of shrimp (Litopenaeus vannamei) shell waste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
GRNT | Written decision to grant | ||
X701 | Decision to grant (after re-examination) | ||
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 4 |
|
R401 | Registration of restoration |